aTyr Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for aTyr Pharma, Inc. (ATYR) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents11.0698.179.98107.9131.6931.1449.55
Short-Term Investments61.0775.6256.17105.5814.740.000.00
Cash & Short-Term Investments72.1398.1766.15107.9131.6931.1449.55
Accounts Receivable1.742.4411.780.442.040.100.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets8.0930.082.9522.2321.7121.300.00
Total Current Assets81.95102.9980.87113.5735.5331.9350.80
Non-Current Assets
Property, Plant & Equipment (Net)11.8614.0511.561.812.984.091.85
Other Non-Current Assets3.023.623.360.160.210.170.09
Total Non-Current Assets14.8817.6614.921.973.204.261.94
Total Assets96.83120.6595.79115.5438.7336.1952.75
Current Liabilities
Accounts Payable4.3215.093.115.035.003.223.07
Short-Term Debt2.500.000.000.000.000.000.00
Accrued Liabilities9.3911.569.864.003.570.000.00
Other Current Liabilities8.142.712.782.331.81-18.670.00
Total Current Liabilities14.9716.4213.866.015.86-5.7510.83
Non-Current Liabilities
Long-Term Debt12.0313.7710.640.401.382.248.26
Other Non-Current Liabilities0.000.000.000.00-16.23-19.340.00
Total Non-Current Liabilities12.0313.7710.640.401.38-15.328.26
Total Liabilities27.0030.1824.506.417.24-21.0719.10
Stockholders' Equity
Common Stock0.080.060.030.030.010.000.00
Retained Earnings-532.05-468.10-417.63-372.56-338.57-322.30-298.70
Accumulated Other Comprehensive Income-0.04-0.07-0.43-0.26-0.04-0.04-0.06
Additional Paid-in Capital602.02558.69489.50481.83370.21343.52332.41
Minority Interest-0.19-0.19-0.18-0.18-0.17-0.160.00
Shares Outstanding84.0463.2929.5027.790.000.000.00
Total Stockholders' Equity69.8390.4771.46109.1331.4821.0333.65
Total Liabilities & Equity96.83120.6595.79115.5438.7336.1952.75